Category Archives: "INforMS"

New multiple sclerosis drug, backed by 40 years of research, could halt disease
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) is holding new hope for [...]
‘MS From the Inside Out’ uses virtual reality to share what life for patients is like
Virtual reality (VR) technology is most commonly associated with gaming and entertainment, but it’s expanding into a variety of clinical [...]
Multiple sclerosis study in cancer breakthrough
A DRUG that helps the immune system destroy cancer has been developed by US scientists. It dramatically shrank deadly skin, brain and [...]
Multiple sclerosis is more complex than once thought: study
Having a disabling disease can making living very difficult, especially when the source of the disability is not well understood. Some [...]
Multiple sclerosis starts five years before onset of disease, study suggests
Symptoms of multiple sclerosis (MS) can appear 5 years before onset of the disease, according to a new study published in Lancet [...]
The hidden costs of multiple sclerosis
MS is sneaky. It is expert at evading detection and diagnosis, and often brings a host of invisible symptoms that may come and go at [...]
What triggers multiple sclerosis? scientists may have identified the culprit
Scientists have identified a cellular mechanism that may be responsible for the development of multiple sclerosis (MS), and could serve as [...]
Vitamin D deficiency affects cognition in multiple sclerosis
Results of a study published in a recent issue of Scientific Reports1 showed significant improvements in cognitive performance among [...]
Nose2brain – project to improve multiple sclerosis therapy
Medically active substances are usually distributed via the blood – either directly or indirectly. In many diseases, however, it is vital [...]
Biogen Idec to present new two-year data from the PLEGRIDY phase 3 advance study
Biogen Idec to Present New Two-Year Data from the PLEGRIDY™ (Peginterferon Beta-1a) Phase 3 Advance Study at AAN Annual [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM